Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
Synucleinopathies of the aging population are an heterogeneous group of neurological disorders that includes Parkinson ’s disease (PD) and dementia with Lewy bodies (DLB) and are characterized by the progressiv...
Source: Molecular Neurodegeneration - Category: Neurology Authors: Changyoun Kim, Brian Spencer, Edward Rockenstein, Hodaka Yamakado, Michael Mante, Anthony Adame, Jerel Adam Fields, Deborah Masliah, Michiyo Iba, He-Jin Lee, Robert A. Rissman, Seung-Jae Lee and Eliezer Masliah Tags: Research article Source Type: research